Just four months after the Food and Drug Administration gave full approval to a new Alzheimer’s drug, it’s estimated that ...

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.

Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among dementia patients as measured by one co-primary endpoint and one secondary endpoint.

Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the ...

Drug shortages in the US continue to affect patients on a daily basis.* Drug shortages range from something as simple as buffered aspirin to life-saving medications such as cancer chemotherapy ...

When it was first approved by the Food and Drug Administration (FDA) in January of this year, the trials showed promising results: The drug had a 27% decline in Alzheimer’s disease over 18 months.

A study has found that Viagra—commonly prescribed to men with erectile dysfunction—could be a potential candidate for treating the degenerative disease. A 93-year-old who barely remembers his ...

Move over, Ozempic — there’s a new drug in town. Eli Lilly’s Zepbound, with the active ingredient tirzepatide, has been approved by the Food and Drug Administration for use by obese or ...

As the sun sets, problems arise - especially for those affected by Alzheimer's disease. This is largely because a change in schedule can cause confusion. It's what the term 'sundowning' means.

The word dementia describes a set of symptoms that may include memory loss and difficulties with thinking, problem-solving or language. Dementia is caused when diseases, such as Alzheimer’s ...

Nov. 8 (UPI) --The Food and Drug Administration on Wednesday authorized the use of a new weight-management treatment offered by Indiana-based drug maker Lilly. FDA officials authorized Zepbound ...